» Articles » PMID: 25388546

The E3 Ubiquitin Ligase RNF121 is a Positive Regulator of NF-κB Activation

Overview
Publisher Biomed Central
Date 2014 Nov 13
PMID 25388546
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The nuclear factor κB (NF-κB) family members regulate several biological processes as cell proliferation and differentiation, inflammation, immunity and tumor progression. Ubiquitination plays a key role in NF-κB activation and the ubiquitylated transmitters of the NF-κB signaling cascade accumulate in close proximity to endomembranes.

Findings: We performed an unbiased siRNA library screen targeting the 46 E3 ubiquitin ligases bearing transmembrane domains to uncover new modulators of NF-κB activation, using tumor necrosis factor-α (TNF-α) receptor (TNFR) stimulation as a model. We report here the identification of a new Golgi Apparatus-resident protein, RNF121, as an enhancer of NF-κB promoter activity through the catalytic function of its RING domain. From a molecular standpoint, while knocking down RNF121 did not alter RIP1 ubiquitination and IKK activation, the proteasomal degradation of IκBα was impaired suggesting that this E3 ubiquitin ligase regulates this process. However, RNF121 did not directly ubiquitinate IκBα While they were found in the same complex. Finally, we discovered that RNF121 acts as a broad regulator of NF-κB signaling since its silencing also dampens NF-κB activation following stimulation of Toll-Like Receptors (TLRs), Nod-Like Receptors (NLRs), RIG-I-Like Receptors (RLRs) or after DNA damages.

Conclusions: These results unveil an unexpected role of Golgi Apparatus and reveal RNF121 as a new player involved in the signaling leading to NF-κB activation.

Citing Articles

Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis.

Cheung B, Mittra R, Murray J, Wang Q, Seneviratne J, Raipuria M Commun Biol. 2024; 7(1):1322.

PMID: 39402275 PMC: 11473750. DOI: 10.1038/s42003-024-06899-8.


Ubiquitin-mediated degradation at the Golgi apparatus.

Buzuk L, Hellerschmied D Front Mol Biosci. 2023; 10:1197921.

PMID: 37484530 PMC: 10357820. DOI: 10.3389/fmolb.2023.1197921.


The RING finger protein family in health and disease.

Cai C, Tang Y, Zhai J, Zheng C Signal Transduct Target Ther. 2022; 7(1):300.

PMID: 36042206 PMC: 9424811. DOI: 10.1038/s41392-022-01152-2.


6-O-angeloylplenolin inhibits anti-IgE-stimulated human mast cell activation via suppressing calcium influx and ERK phosphorylation.

Yu Y, Lin D, Liu Z, Fang R, Zheng S, Cheng Y Iran J Basic Med Sci. 2022; 25(5):629-634.

PMID: 35911641 PMC: 9282743. DOI: 10.22038/IJBMS.2022.64132.14120.


Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation.

Nishitsuji H, Iwahori S, Ohmori M, Shimotohno K, Murata T mBio. 2022; 13(4):e0097122.

PMID: 35856559 PMC: 9426613. DOI: 10.1128/mbio.00971-22.


References
1.
Read M, Brownell J, Gladysheva T, Hottelet M, Parent L, Coggins M . Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol. 2000; 20(7):2326-33. PMC: 85397. DOI: 10.1128/MCB.20.7.2326-2333.2000. View

2.
Alexia C, Poalas K, Carvalho G, Zemirli N, Dwyer J, Dubois S . The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor κB signaling. Sci Signal. 2013; 6(291):ra79. DOI: 10.1126/scisignal.2004496. View

3.
YARON A, Hatzubai A, Davis M, Lavon I, Amit S, Manning A . Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature. 1998; 396(6711):590-4. DOI: 10.1038/25159. View

4.
Winston J, Strack P, Chu C, Elledge S, Harper J . The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999; 13(3):270-83. PMC: 316433. DOI: 10.1101/gad.13.3.270. View

5.
Spencer E, Jiang J, Chen Z . Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev. 1999; 13(3):284-94. PMC: 316434. DOI: 10.1101/gad.13.3.284. View